Core A: Administrative Core
Core A: Administrative Core
批准号:
10363642
负责人:
Steven P. Balk
金额:
$8.66万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-05-24 至 2024-01-31
关键词:
AddressAdministratorAndrogen ReceptorBiologicalBiometryCancer CenterCell LineClinicClinicalClinical DistributionClinical InvestigatorClinical TrialsClinical Trials DesignCodeCollaborationsCommunicationComputational BiologyConsultationsDana-Farber Cancer InstituteDataDiseaseEnsureExperimental DesignsFoundationsGene ExpressionGoalsGrantGroup MeetingsImageInstitutionIntervention TrialIsraelLaboratory FindingLaboratory StudyMedical centerPathologicPatientsPhase I Clinical TrialsPhase I/II Clinical TrialPhase II Clinical TrialsPhysiologicalProteinsRelapseReproducibilityResourcesSample SizeSamplingStatistical Data InterpretationTissuesTranslatingUniversitiesWashingtonXenograft Modelbasecastration resistant prostate cancerclinically relevantclinically significantdesigninsightpre-clinicalpreclinical developmentpreclinical studypreclinical trialresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Administrative Core (Core A) has fulfilled three major functions during the current grant,
and will continue to do so in this renewal. One function is the overall management of the P01,
which is the responsibility of the PI, Steven Balk, with an administrator and in consultation with
the other PIs. This includes addressing all administrative issues, organizing group meetings,
organizing internal and external reviews, and in general facilitating communications and
collaborations. The second function of the Core has been to assist the Projects in efforts to
ensure that their laboratory studies and findings are physiologically significant, and ultimately to
translate their findings into patients. This has been facilitated by close interactions with our
clinicians, represented by our internal advisory board. Through previous/ongoing clinical trials
and tissue banking efforts at their respective institutions, these clinical investigators have
collected (and continue to collect) valuable samples from patients at varying stages of their
disease and after varying therapies. In discussions with the Project Leaders, they have provided
relevant clinical samples for analysis and have provided further insight into potential biological
significance of laboratory findings. The third Core function is to provide statistical support for
each of the Project Leaders in their experimental designs. The Specific Aims are 1) Provide
administrative support to insure that the goals of the project are achieved, 2) Assist in
translating the results from each Project into the clinic, 3) Provide biostatistical support for each
Project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DF/HCC Prostate SPORE
-
批准号:10628270
-
项目类别:
-
资助金额:$258.56万
-
财政年份:2023
-
负责人:Steven P. Balk
-
依托单位:
WNT5a/ROR2-Mediated Hippo Pathway Activation in Prostate Cancer
-
批准号:10734173
-
项目类别:
-
资助金额:$39.55万
-
财政年份:2023
-
负责人:Steven P. Balk
-
依托单位:
Enhancing the Efficacy of Docetaxel in Prostate Cancer
-
批准号:10665071
-
项目类别:
-
资助金额:$64.14万
-
财政年份:2022
-
负责人:Steven P. Balk
-
依托单位:
Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs
-
批准号:10407648
-
项目类别:
-
资助金额:$39.23万
-
财政年份:2021
-
负责人:Steven P. Balk
-
依托单位:
Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs
-
批准号:10279279
-
项目类别:
-
资助金额:$40.03万
-
财政年份:2021
-
负责人:Steven P. Balk
-
依托单位:
SOX9 Mediation of AR and ERG Driven Prostate Cancer
-
批准号:9477598
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2014
-
负责人:Steven P. Balk
-
依托单位:
SOX9 Mediation of AR and ERG Driven Prostate Cancer
-
批准号:8653225
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2014
-
负责人:Steven P. Balk
-
依托单位:
SOX9 Mediation of AR and ERG Driven Prostate Cancer
-
批准号:9269164
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2014
-
负责人:Steven P. Balk
-
依托单位:
Androgen Receptor Action in Castration Resistant Prostate Cancer
-
批准号:8475909
-
项目类别:
-
资助金额:$218.35万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Project 2: Mechanisms Driving AR Full Length and Splice Variant Activities and Antagonist Resistance
-
批准号:10363640
-
项目类别:
-
资助金额:$23.74万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Androgen Receptor Action in Castration Resistant Prostate Cancer
-
批准号:10363638
-
项目类别:
-
资助金额:$142.94万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Androgen Receptor Action in Castration Resistant Prostate Cancer
-
批准号:10576935
-
项目类别:
-
资助金额:$143.19万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Project 2: Mechanisms Driving AR Full Length and Splice Variant Activities and Antagonist Resistance
-
批准号:10576938
-
项目类别:
-
资助金额:$23.75万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Basis for Androgen Receptor Antagonist Resistance in CRPC
-
批准号:8475911
-
项目类别:
-
资助金额:$29.28万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Androgen Receptor Action in Castration Resistant Prostate Cancer
-
批准号:8665884
-
项目类别:
-
资助金额:$201.08万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Androgen Receptor Action in Castration Resistant Prostate Cancer
-
批准号:9099781
-
项目类别:
-
资助金额:$204.51万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Administrative/Clinical/Biostatistics Core
-
批准号:8475914
-
项目类别:
-
资助金额:$14.15万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Core A: Administrative Core
-
批准号:10576941
-
项目类别:
-
资助金额:$8.82万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Targeting androgen receptor signaling in prostate cancer in men with African ancestry
-
批准号:10490377
-
项目类别:
-
资助金额:$9.63万
-
财政年份:2010
-
负责人:Steven P. Balk
-
依托单位:
Targeting androgen receptor signaling in prostate cancer in men with African ancestry
-
批准号:10693241
-
项目类别:
-
资助金额:$17.15万
-
财政年份:2010
-
负责人:Steven P. Balk
-
依托单位:
海外基金